All fields · Hematology

JournalQ1· SCImago 2025

Blood

ISSN 0006-4971

• Q1Quartile
• 5.00SJR
• 556h-index
• 21papers summarised

About this journal

Blood is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 5.00 and an h-index of 556. Most of its papers in the Pofolia pool fall under Hematology. Pofolia holds AI summaries of 21 paper(s) from this journal; the most cited is “The 2016 revision to the World Health Organization classification of myeloid neoplasms…” (10237 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?

Papers we summarise from this journal

• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia2016 · 10237 citations
• The 2016 revision of the World Health Organization classification of lymphoid neoplasms2016 · 7845 citations
• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel2016 · 5899 citations
• Revised International Prognostic Scoring System for Myelodysplastic Syndromes2012 · 3155 citations
• Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN2022 · 3068 citations
• International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data2022 · 2739 citations
• A systematic analysis of global anemia burden from 1990 to 20102013 · 2092 citations
• European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 20132013 · 1992 citations
• Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes2015 · 1944 citations
• Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia2018 · 1862 citations
• Clinical and biological implications of driver mutations in myelodysplastic syndromes2013 · 1844 citations
• iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL2018 · 1706 citations
• Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study2017 · 1700 citations
• The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee2022 · 1524 citations
• Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia2017 · 1476 citations
• The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas2019 · 1392 citations
• Epidemiology of cancer-associated venous thrombosis2013 · 1202 citations
• International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts2015 · 1152 citations
• Anemia of inflammation2018 · 1130 citations
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials2014 · 843 citations
• Venous thromboembolism in cancer patients: a population-based cohort study2020 · 707 citations

Journals in the same field

See every journal in the field →